Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luana Fianchi

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|April 26, 2002
Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centresLivio Pagano, Luana Fianchi, Luca Mele, et al.
Journal of Fungi (Basel, Switzerland)|June 23, 2022
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM StudyChiara Cattaneo, Francesco Marchesi, Irene Terrenato, et al.
Frontiers in Microbiology|August 30, 2016
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive AspergillosisCarmen B Lupiañez, María T Villaescusa, Agostinho Carvalho, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 13, 2017
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric RegistryFlavia Mayer, Laura Faglioni, Nera Agabiti, et al.
American Journal of Hematology|February 6, 2015
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemiasLuana Fianchi, Livio Pagano, Alfonso Piciocchi, et al.
Hemasphere|September 4, 2023
Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMAFabio Efficace, Wael Al Essa, Uwe Platzbecker, et al.
Blood Advances|October 25, 2024
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OSThomas Cluzeau, Fabio Guolo, Edmond Chiche, et al.
Haematologica|October 24, 2009
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry studyLivio Pagano, Morena Caira, Anna Candoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic SyndromesGuillermo Garcia-Manero, Valeria Santini, Antonio Almeida, et al.
Annals of Hematology|May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life studyLuana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|April 26, 2002
Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centresLivio Pagano, Luana Fianchi, Luca Mele, et al.
Journal of Fungi (Basel, Switzerland)|June 23, 2022
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM StudyChiara Cattaneo, Francesco Marchesi, Irene Terrenato, et al.
Frontiers in Microbiology|August 30, 2016
Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive AspergillosisCarmen B Lupiañez, María T Villaescusa, Agostinho Carvalho, et al.
Mediterranean Journal of Hematology and Infectious Diseases|July 13, 2017
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric RegistryFlavia Mayer, Laura Faglioni, Nera Agabiti, et al.
American Journal of Hematology|February 6, 2015
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemiasLuana Fianchi, Livio Pagano, Alfonso Piciocchi, et al.
Hemasphere|September 4, 2023
Health-related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real-world Study by the GIMEMAFabio Efficace, Wael Al Essa, Uwe Platzbecker, et al.
Blood Advances|October 25, 2024
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OSThomas Cluzeau, Fabio Guolo, Edmond Chiche, et al.
Haematologica|October 24, 2009
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry studyLivio Pagano, Morena Caira, Anna Candoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic SyndromesGuillermo Garcia-Manero, Valeria Santini, Antonio Almeida, et al.
Annals of Hematology|May 24, 2025
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life studyLuana Fianchi, Alfonso Piciocchi, Fabio Guolo, et al.
Pageof 10